Skip to content

MiMedx Group MDXG Shares (Basic)

Shares (Basic) at other companies

IAR
Integra LifeSciencesIART
77M+0.6%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
127.8M+1.2%
Solventum logo
SolventumSOLV
174.2M+0.3%
Vericel logo
VericelVCEL
50.8M+1.7%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
22.6M-4.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.1%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's shares (basic)?
MiMedx Group (MDXG) reported shares (basic) of 148.4M in Q1 2026.
How has MiMedx Group's shares (basic) changed year-over-year?
MiMedx Group's shares (basic) increased by 0.8% year-over-year, from 147.3M to 148.4M.
What is the long-term trend for MiMedx Group's shares (basic)?
Over 4 years (2021 to 2025), MiMedx Group's shares (basic) has grown at a 7.6% compound annual growth rate (CAGR), from 440.7M to 590.9M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.